UTHR

United Therapeutics Corporation (UTHR)

About United Therapeutics Corporation (UTHR)

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Details

Daily high

$319.07

Daily low

$307.64

Price at open

$315.17

52 Week High

$417.82

52 Week Low

$221.53

Market cap

14.1B

Dividend yield

0.00%

Volume

354,972

Avg. volume

641,420

P/E ratio

12.77

United Therapeutics Corporation News